BiomX Inc (PHGE)
0.3798
+0.03
(+8.51%)
USD |
NYAM |
Apr 29, 16:00
0.38
0.00 (0.00%)
After-Hours: 07:00
BiomX Cash from Investing (TTM): 1.951M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 1.951M |
September 30, 2023 | 3.425M |
June 30, 2023 | 7.956M |
March 31, 2023 | 9.903M |
December 31, 2022 | -2.107M |
September 30, 2022 | -3.678M |
June 30, 2022 | -9.488M |
March 31, 2022 | 0.985M |
December 31, 2021 | 16.17M |
Date | Value |
---|---|
September 30, 2021 | 6.468M |
June 30, 2021 | 7.586M |
March 31, 2021 | -5.36M |
December 31, 2020 | -10.86M |
September 30, 2020 | -0.8787M |
June 30, 2020 | -0.6857M |
March 31, 2020 | -0.1587M |
September 30, 2019 | -69.83M |
June 30, 2019 | -70.00M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-70.00M
Minimum
Jun 2019
16.17M
Maximum
Dec 2021
-6.589M
Average
-0.4222M
Median
Cash from Investing (TTM) Benchmarks
Taro Pharmaceutical Industries Ltd | 148.21M |
InspireMD Inc | -16.09M |
Alpha Tau Medical Ltd | -- |
Pluri Inc | 12.36M |
Raphael Pharmaceutical Inc | -- |